MA23687A1 - Utilisation et composition d'une formulation contre les maladies sexuellement transmissibles - Google Patents

Utilisation et composition d'une formulation contre les maladies sexuellement transmissibles

Info

Publication number
MA23687A1
MA23687A1 MA24032A MA24032A MA23687A1 MA 23687 A1 MA23687 A1 MA 23687A1 MA 24032 A MA24032 A MA 24032A MA 24032 A MA24032 A MA 24032A MA 23687 A1 MA23687 A1 MA 23687A1
Authority
MA
Morocco
Prior art keywords
composition
stds
infectant
std
sexually transmitted
Prior art date
Application number
MA24032A
Other languages
English (en)
Original Assignee
Columbia Lab Inc
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Inc, Columbia Lab Bermuda Ltd filed Critical Columbia Lab Inc
Publication of MA23687A1 publication Critical patent/MA23687A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA24032A 1994-10-07 1995-10-06 Utilisation et composition d'une formulation contre les maladies sexuellement transmissibles MA23687A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
MA23687A1 true MA23687A1 (fr) 1996-07-01

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24032A MA23687A1 (fr) 1994-10-07 1995-10-06 Utilisation et composition d'une formulation contre les maladies sexuellement transmissibles

Country Status (24)

Country Link
US (2) US5667492A (fr)
EP (1) EP0784466B1 (fr)
JP (1) JPH10507178A (fr)
KR (1) KR970705976A (fr)
AT (1) ATE213623T1 (fr)
AU (1) AU704836B2 (fr)
BR (1) BR9509280A (fr)
CA (1) CA2201872A1 (fr)
CO (1) CO4480018A1 (fr)
DE (1) DE69525634T2 (fr)
DK (1) DK0784466T3 (fr)
ES (1) ES2173203T3 (fr)
FI (1) FI971440A (fr)
HU (1) HUT77527A (fr)
IL (1) IL115495A0 (fr)
MA (1) MA23687A1 (fr)
MX (1) MX9504245A (fr)
NO (1) NO971491L (fr)
NZ (1) NZ295947A (fr)
PE (1) PE46996A1 (fr)
PT (1) PT784466E (fr)
RU (1) RU2157184C2 (fr)
WO (1) WO1996010989A1 (fr)
ZA (1) ZA958434B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
AU7484198A (en) * 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
EP1356806A1 (fr) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited Composition pharmaceutique destinée au traitement des dysmenorrhées et de l'accouchement prématuré
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
CA2335055A1 (fr) 1998-06-19 1999-12-23 Jack Fellman Dispositif medical a proprietes anti-infectieuses et contraceptives
AU4489399A (en) * 1998-06-23 2000-01-10 Notax Holding Gesellschaft M.B.H. Use of nonoxynol-9 as lubricant and method for its production
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
RU2310474C2 (ru) 1999-10-05 2007-11-20 Колумбия Лабораториз (Бермуда) Лимитед Способ лечения эндометриоза или бесплодия или улучшение способности к воспроизведению потомства и фармацевтическая композиция для его осуществления
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
HU230315B1 (hu) 2000-03-07 2016-01-28 Rush-Presbyterian-St. Luke's Medical Center Összetételek és eljárások patogén mikrobák és spermatozoák csapdázására
ES2437846T3 (es) * 2001-02-15 2014-01-14 Access Pharmaceuticals, Inc. Formulaciones líquidas para la prevención y el tratamiento de enfermedades y trastornos de la mucosa
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
PL371945A1 (en) * 2001-10-16 2005-07-11 Avanir Pharmacueticals Viral inhibition by n-docosanol
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
KR20110132482A (ko) 2003-02-07 2011-12-07 얀센 파마슈티카 엔.브이. Ｈｉｖ 감염 예방용 피리미딘 유도체
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
CN110693812A (zh) * 2012-06-13 2020-01-17 伊沃菲姆股份有限公司 用于增强避孕杀微生物剂有效性的组合物和方法
US11337989B2 (en) 2013-12-19 2022-05-24 Evofem, Inc. Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
WO2016008039A1 (fr) * 2014-07-14 2016-01-21 Novicol International Holding Inc. Composition microbicide comprenant un octoxynole et un composé alcaloïde de quinolizidine ou une source de celui-ci
CN110225750A (zh) 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE604564A (fr) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
EP0077063B1 (fr) * 1981-10-13 1988-03-16 Exovir, Inc. Compositions contenant de l'interféron et application de ces compositions dans le traitement des infections herpétiques, lésions prémalignes de la peau, malignités de la peau et psoriasis
EP0163696B1 (fr) * 1983-11-14 1992-11-25 Columbia Laboratories, Inc. Application d'une bioadhesive
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
ATE112157T1 (de) * 1989-10-31 1994-10-15 Columbia Lab Inc Verfahren zur feuchthaltung von gewebe und mittel dazu.
EP0431719B1 (fr) * 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Composition pour hydrater le tissu vaginal
EP0500807B1 (fr) * 1989-10-31 1999-07-07 Columbia Laboratories, Inc. Procede et composition d'humidification de tissu
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Also Published As

Publication number Publication date
NZ295947A (en) 1999-02-25
EP0784466A1 (fr) 1997-07-23
US5667492A (en) 1997-09-16
FI971440A0 (fi) 1997-04-07
AU3961295A (en) 1996-05-02
NO971491D0 (no) 1997-04-02
PE46996A1 (es) 1996-11-23
ZA958434B (en) 1996-05-08
KR970705976A (ko) 1997-11-03
NO971491L (no) 1997-06-09
US20010006667A1 (en) 2001-07-05
RU2157184C2 (ru) 2000-10-10
PT784466E (pt) 2002-06-28
AU704836B2 (en) 1999-05-06
JPH10507178A (ja) 1998-07-14
FI971440A (fi) 1997-04-07
DK0784466T3 (da) 2002-04-22
DE69525634D1 (de) 2002-04-04
WO1996010989A1 (fr) 1996-04-18
HUT77527A (hu) 1998-05-28
ES2173203T3 (es) 2002-10-16
CA2201872A1 (fr) 1996-04-18
CO4480018A1 (es) 1997-07-09
ATE213623T1 (de) 2002-03-15
MX9504245A (es) 1997-01-31
DE69525634T2 (de) 2002-08-29
BR9509280A (pt) 1997-11-18
EP0784466B1 (fr) 2002-02-27
IL115495A0 (en) 1996-01-19

Similar Documents

Publication Publication Date Title
MA23687A1 (fr) Utilisation et composition d'une formulation contre les maladies sexuellement transmissibles
US5071644A (en) Topical drug delivery with thermo-irreversible gels
US5387611A (en) Use of butylurea, nonoxynol-9 and benzalkonium chloride as anti-bacterial, anti-viral contraceptive agents
JPS62234017A (ja) 膣用医薬組成物
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
ES2079994B1 (es) Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
KR940005290A (ko) 생점착성 치료 조성물 및 사용방법
CA2111932A1 (fr) Desinfectant en gel a sechage rapide pour mains et doigts
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
IL114193A0 (en) Ophthalmic pharmaceutical compositions
DE69523733D1 (de) Thermisch gelierende trägerstoffe zur arzneistoffabgabe, die zelluloseether enthalten
ES2045470T3 (es) Formulaciones medicinales en aerosol.
MXPA03000712A (es) Composiciones farmaceuticas para el tratamiento de condiciones ulcerativas, dolorosas e inflamatorias de superficies epiteliales humedas tales como mucositis, estomatitis y sindorme de behcet.
MX9305535A (es) Composiciones y concentrados germicidas a base de yodo-detergente, acuosos y estables.
JPH08133911A (ja) 抗菌組成物
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DK173716B1 (da) Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse
ATE359066T1 (de) Pflaster mit 4-biphenylessigsäure
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.